Page last updated: 2024-09-04

irofulven and Melanoma

irofulven has been researched along with Melanoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eckhardt, SG; Gibbs, P; Gonzalez, R; Pierson, AS; Richards, J; Russ, P	1
Kashimoto, S; MacDonald, JR; Nakano, K; Sato, Y	1

Trials

1 trial(s) available for irofulven and Melanoma

Article	Year
A phase II study of Irofulven (MGI 114) in patients with stage IV melanoma. Investigational new drugs, 2002, Volume: 20, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Female; Humans; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Sesquiterpenes	2002

Other Studies

1 other study(ies) available for irofulven and Melanoma

Article	Year
In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:11 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Humans; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Sesquiterpenes; Stomach Neoplasms; Xenograft Model Antitumor Assays	2001

Article

Year

In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours.

European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:11

Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Humans; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Sesquiterpenes; Stomach Neoplasms; Xenograft Model Antitumor Assays

2001